Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transition Therapeutics Inc (NASDAQ:TTHI)

1.49
Delayed Data
As of Aug 26
 +0.01 / +0.68%
Today’s Change
0.66
Today|||52-Week Range
2.75
-22.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.0017.9M0.000.00
 
 
Depreciation And Amortization1.8M1.8M884.9K555.6K
 
 
 
 
 
 
Operating ExpensesGross Income-1.8M---884.9K-555.6K
 
 
 
 
General Expenses10.7M10.6M20.0M46.1M
 
 
 
 
 
Research And Development6.4M7.0M15.6M41.4M
 
 
 
 
 
Total Operating Expenses12.6M12.4M20.9M46.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.6M5.5M-20.9M-46.7M
 
 
 
 
 
Extraordinary Credit0.000.002.7M0.00
 
 
Extraordinary Charge0.00-6.5M-2.9M-56.1K
 
 
 
 
Other Expenses170.4K905.8K258.4K2.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.2M23.2K-20.6M-43.8M
 
 
 
 
 
Income Taxes0.000.00-230.4K0.00
 
 
Net Income-12.2M23.2K-20.4M-43.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.4M26.8M30.1M36.5M
 
 
 
 
 
Shares To Calculate EPS Diluted25.4M26.8M30.1M36.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48$0.00-$0.67-$1.20
 
 
 
 
EPS Diluted-$0.48$0.00-$0.67-$1.20